Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Cefinox 400 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Cefinox 400

Approved

STANDARD

Cefinox 400

Innova Captab Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 998e1b08664a9903
Company: Innova Captab Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: 998e1b08664a9903
Drug Approval Philippines Name: Cefinox 400
Product Name: Cefinox 400
Registration Number: DRP-13949
Brand Name: Cefinox 400
Generic Name: Cefixime (as trihydrate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 400 mg
Manufacturer: Innova Captab Pvt. Ltd.
Importer: Pharmakon Biotec Inc.
Distributor: Pharmakon Biotec Inc.
Issuance Date: 24 May 2023
Expiry Date: 24 May 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

998e1b08664a9903

Type

Standard

Back to Philippines FDA Approvals